170 related articles for article (PubMed ID: 32075106)
1. Phosphorylation-Dependent Differences in CXCR4-LASP1-AKT1 Interaction between Breast Cancer and Chronic Myeloid Leukemia.
Butt E; Stempfle K; Lister L; Wolf F; Kraft M; Herrmann AB; Viciano CP; Weber C; Hochhaus A; Ernst T; Hoffmann C; Zernecke A; Frietsch JJ
Cells; 2020 Feb; 9(2):. PubMed ID: 32075106
[TBL] [Abstract][Full Text] [Related]
2. Knockout of LASP1 in CXCR4 expressing CML cells promotes cell persistence, proliferation and TKI resistance.
Herrmann AB; Müller ML; Orth MF; Müller JP; Zernecke A; Hochhaus A; Ernst T; Butt E; Frietsch JJ
J Cell Mol Med; 2020 Mar; 24(5):2942-2955. PubMed ID: 31957290
[TBL] [Abstract][Full Text] [Related]
3. LASP1 is a novel BCR-ABL substrate and a phosphorylation-dependent binding partner of CRKL in chronic myeloid leukemia.
Frietsch JJ; Kastner C; Grunewald TG; Schweigel H; Nollau P; Ziermann J; Clement JH; La Rosée P; Hochhaus A; Butt E
Oncotarget; 2014 Jul; 5(14):5257-71. PubMed ID: 24913448
[TBL] [Abstract][Full Text] [Related]
4. COPS5 and LASP1 synergistically interact to downregulate 14-3-3σ expression and promote colorectal cancer progression via activating PI3K/AKT pathway.
Zhou R; Shao Z; Liu J; Zhan W; Gao Q; Pan Z; Wu L; Xu L; Ding Y; Zhao L
Int J Cancer; 2018 May; 142(9):1853-1864. PubMed ID: 29226323
[TBL] [Abstract][Full Text] [Related]
5. LIM and SH3 protein 1 induces glioma growth and invasion through PI3K/AKT signaling and epithelial-mesenchymal transition.
Zhong C; Li X; Tao B; Peng L; Peng T; Yang X; Xia X; Chen L
Biomed Pharmacother; 2019 Aug; 116():109013. PubMed ID: 31146105
[TBL] [Abstract][Full Text] [Related]
6. Loss of the 14-3-3σ is essential for LASP1-mediated colorectal cancer progression via activating PI3K/AKT signaling pathway.
Shao Z; Cai Y; Xu L; Yao X; Shi J; Zhang F; Luo Y; Zheng K; Liu J; Deng F; Li R; Zhang L; Wang H; Li M; Ding Y; Zhao L
Sci Rep; 2016 May; 6():25631. PubMed ID: 27156963
[TBL] [Abstract][Full Text] [Related]
7. LASP1 promotes proliferation, metastasis, invasion in head and neck squamous cell carcinoma and through direct interaction with HSPA1A.
Chen Q; Wu K; Qin X; Yu Y; Wang X; Wei K
J Cell Mol Med; 2020 Jan; 24(2):1626-1639. PubMed ID: 31793711
[TBL] [Abstract][Full Text] [Related]
8. LASP1 in Cellular Signaling and Gene Expression: More than Just a Cytoskeletal Regulator.
Butt E; Howard CM; Raman D
Cells; 2022 Nov; 11(23):. PubMed ID: 36497077
[TBL] [Abstract][Full Text] [Related]
9. Regulation of matrix metalloproteinases (MMPs) expression and secretion in MDA-MB-231 breast cancer cells by LIM and SH3 protein 1 (LASP1).
Endres M; Kneitz S; Orth MF; Perera RK; Zernecke A; Butt E
Oncotarget; 2016 Sep; 7(39):64244-64259. PubMed ID: 27588391
[TBL] [Abstract][Full Text] [Related]
10. LASP1 promotes nasopharyngeal carcinoma progression through negatively regulation of the tumor suppressor PTEN.
Gao Q; Tang L; Wu L; Li K; Wang H; Li W; Wu J; Li M; Wang S; Zhao L
Cell Death Dis; 2018 Mar; 9(3):393. PubMed ID: 29531214
[TBL] [Abstract][Full Text] [Related]
11. LIM and SH3 protein 1 regulates cell growth and chemosensitivity of human glioblastoma via the PI3K/AKT pathway.
Zhong C; Chen Y; Tao B; Peng L; Peng T; Yang X; Xia X; Chen L
BMC Cancer; 2018 Jul; 18(1):722. PubMed ID: 29980193
[TBL] [Abstract][Full Text] [Related]
12. The CXCR4-Dependent LASP1-Ago2 Interaction in Triple-Negative Breast Cancer.
Tilley AMC; Howard CM; Sridharan S; Subramaniyan B; Bearss NR; Alkhalili S; Raman D
Cancers (Basel); 2020 Aug; 12(9):. PubMed ID: 32872485
[TBL] [Abstract][Full Text] [Related]
13. An update on the LIM and SH3 domain protein 1 (LASP1): a versatile structural, signaling, and biomarker protein.
Orth MF; Cazes A; Butt E; Grunewald TG
Oncotarget; 2015 Jan; 6(1):26-42. PubMed ID: 25622104
[TBL] [Abstract][Full Text] [Related]
14. [Expression of LIM and SH3 protein 1 in renal clear cell carcinoma and its effects on invasion and migration of renal clear cell carcinoma 786-O cells].
Jin B; Gao L; Li W; Chen JC; Wen RM; Wang JQ
Zhonghua Zhong Liu Za Zhi; 2017 Mar; 39(3):166-171. PubMed ID: 28316213
[No Abstract] [Full Text] [Related]
15. Loss of tumor suppressor mir-203 mediates overexpression of LIM and SH3 Protein 1 (LASP1) in high-risk prostate cancer thereby increasing cell proliferation and migration.
Hailer A; Grunewald TG; Orth M; Reiss C; Kneitz B; Spahn M; Butt E
Oncotarget; 2014 Jun; 5(12):4144-4153. PubMed ID: 24980827
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-203 suppresses cell proliferation and migration by targeting BIRC5 and LASP1 in human triple-negative breast cancer cells.
Wang C; Zheng X; Shen C; Shi Y
J Exp Clin Cancer Res; 2012 Jun; 31(1):58. PubMed ID: 22713668
[TBL] [Abstract][Full Text] [Related]
17. LASP1 in Tumor and Tumor Microenvironment.
Hu Z; Wang X; Cui Y; Li C; Wang S
Curr Mol Med; 2017; 17(8):541-548. PubMed ID: 29473505
[TBL] [Abstract][Full Text] [Related]
18. EPS8 regulates proliferation, apoptosis and chemosensitivity in BCR-ABL positive cells via the BCR-ABL/PI3K/AKT/mTOR pathway.
Huang R; Liu H; Chen Y; He Y; Kang Q; Tu S; He Y; Zhou X; Wang L; Yang J; Wu A; Li Y
Oncol Rep; 2018 Jan; 39(1):119-128. PubMed ID: 29192326
[TBL] [Abstract][Full Text] [Related]
19. FAM168A participates in the development of chronic myeloid leukemia via BCR-ABL1/AKT1/NFκB pathway.
Liu X; Mai H; Jiang H; Xing Z; Peng D; Kong Y; Zhu C; Chen Y
BMC Cancer; 2019 Jul; 19(1):679. PubMed ID: 31291942
[TBL] [Abstract][Full Text] [Related]
20. LIM and SH3 protein 1 induces TGFβ-mediated epithelial-mesenchymal transition in human colorectal cancer by regulating S100A4 expression.
Wang H; Shi J; Luo Y; Liao Q; Niu Y; Zhang F; Shao Z; Ding Y; Zhao L
Clin Cancer Res; 2014 Nov; 20(22):5835-47. PubMed ID: 25252758
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
